Skip to main content

Table 2 Advantages and disadvantages of dabigatran over VKA

From: Pharmacological basis and clinical evidence of dabigatran therapy

Advantages over VKA

Disadvantages over VKA

No need of periodic INR control

High prize

Lower interactions

Not indicated in renal disease

Favorable safety versus efficacy profile, it may reduce VKA misdosing

No antidote and lack of experience in hemorrhage complications